Hypercholesterolemia Abrogates Late Preconditioning via a Tetrahydrobiopterin-Dependent Mechanism in Conscious Rabbits
- 4 October 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 112 (14), 2149-2156
- https://doi.org/10.1161/circulationaha.105.566190
Abstract
Background— Although the late phase of ischemic preconditioning (PC) is known to confer cardioprotection in healthy animal models, it is unknown whether this phenomenon exists in the presence of hypercholesterolemia. The goal of this study was to determine whether the infarct-sparing effect of late PC is affected by hypercholesterolemia and, if so, whether a tetrahydrobiopterin (BH 4 )-dependent mechanism is responsible for the loss of late PC. Methods and Results— Conscious rabbits fed a normal diet or a 1% cholesterol diet for 6 weeks were subjected to ischemic PC (six 4-minute coronary occlusion/4-minute reperfusion cycles) and, 24 hours later, underwent a 30-minute occlusion followed by 3 days of reperfusion. A total of 125 rabbits were used. In normocholesterolemic rabbits, ischemic PC reduced infarct size, an effect that was abrogated by administration of the BH 4 synthesis inhibitor N -acetylserotonin (15 mg/kg IV) before the 30-minute occlusion. In hypercholesterolemic rabbits, however, ischemic PC failed to reduce infarct size. Myocardial BH 4 levels in the ischemic zone increased 24 hours after ischemic PC in normocholesterolemic rabbits but not in hypercholesterolemic rabbits. In addition, in normocholesterolemic rabbits, pretreatment with N -acetylserotonin completely abolished the ischemic PC-induced increase in myocardial BH 4 levels. Conclusions— This study demonstrates that (1) hypercholesterolemia abrogates both the infarct-sparing effect of late PC and the concomitant upregulation of myocardial BH 4 , and (2) inhibition of myocardial BH 4 synthesis in the absence of hypercholesterolemia is sufficient to abolish the infarct-sparing effect of late PC. The results support the concept that hypercholesterolemia abrogates late PC by preventing the upregulation of BH 4 , an essential cofactor for inducible nitric oxide synthase.Keywords
This publication has 34 references indexed in Scilit:
- Exogenous NO suppresses flow-induced endothelium-derived NO production because of depletion of tetrahydrobiopterinAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- The Autoxidation of Tetrahydrobiopterin RevisitedJournal of Biological Chemistry, 2003
- Myocardial ischaemia/reperfusion injury and preconditioning: effects of hypercholesterolaemia/hyperlipidaemiaBritish Journal of Pharmacology, 2003
- Attenuation of increased myocardial ischaemia-reperfusion injury conferred by hypercholesterolaemia through pharmacological inhibition of the caspase-1 cascadeBritish Journal of Pharmacology, 2003
- Altered Tetrahydrobiopterin Metabolism in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Delayed Cardiac Protection Against Harmful Consequences of Stress can be Induced in Experimental Atherosclerosis in RabbitsJournal of Molecular and Cellular Cardiology, 1997
- Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioningCardiovascular Research, 1994
- Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs.JCI Insight, 1993
- Hypercholesterolemia increases endothelial superoxide anion production.JCI Insight, 1993